Application no. and date | 14771729.2 (espacenet) (Federated) (European Patent Register), 20140910 | Patent/reg. no. and date | DK/EP 3044231, 20200805 | Publication date | 20160720 | Priority no. and date | US 201361877042 P, 20130912 | EP pub. no. and date |
EP 3044231 20160720 | Effective date | | Applicant/owner | BioMarin Pharmaceutical Inc., 105 Digital Drive
Novato, CA 94949, US, University College London, Gower Street
London WC1E 6BT, GB, St. Jude Children's Research Hospital, 262 Danny Thomas Place
Memphis, TN 38105-3678, US | Applicant ref. no. | 1554330 | Inventor | COLOSI, Peter Cameron, 248 Redwood Road
San Anselmo, CA 94960, US, NATHWANI, Amit, c/o UCL Cancer Institute 72 Huntley Street
London, WC1E 6HX, GB, MCINTOSH, Jenny, c/o UCL Cancer Institute 72 Huntley Street
London, WC1E 6HX, GB, TUDDENHAM, Edward, c/o UCL Cancer Institute 72 Huntley Street
London, WC1E 6HX, GB, DAVIDOFF, Andrew, c/o St. Jude Children's Research Hospital 262 Danny Thomas Place
Memphis, Tennessee 38105-3678, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 48/00 (2006.01) , C07K 14/755 (2006.01) , C12N 15/86 (2006.01) | Title | AAV-VEKTORER, DER OMFATTER EN GENKODNINGSFAKTOR VIII
PRIMÆR ANMODNING | Int. application no. | US2014054960 | Int. publication no. | WO2015038625 | Related patent (certificate) | CA 2023 00003 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|